ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Biological Assessment of Stevioside and Sucralose as Sucrose Substitutes for Diabetics on STZ-Induced Diabetes in Rats.

糖尿病ラットにおけるスクロース代替甘味料としてのステビオサイドとスクラロースの生物学的評価 (機械翻訳の邦題)

Molecules (Basel, Switzerland)2023Barakat H, Al-Roug K, Algonaiman R, et al.
研究デザインその他の原著論文
対象ヒト・動物 併記

記録の確認項目

研究デザイン
その他の原著論文
対象
ヒト・動物 併記
出版年
2023
出典
doi.org
抄録の表示
表示あり
出版状態
有効な記録
状態確認日
2026/08/17
収集日
2026/08/03
鮮度
確認期限内
確認段階
自動処理
記録状態
公開

日本語要約(機械生成)

本研究では、STZ誘発糖尿病ラットを用いて、スクロース代替甘味料であるステビオサイド(ST)とスクラロース(SU)の単独および併用投与の影響を評価した。正常ラットではSUが最も望ましくない体重増加への影響を示した。糖尿病ラットでは、いずれの処理も体重増加を改善せず、インスリン併用により改善が見られ、ST群で最も良好だった。血糖値はSTおよびST+SUで低下したが、SU単独では効果がなかった。血清インスリンはSUで減少し、STで改善した。ALTへの影響はSUで認められず、総ビリルビンはインスリン併用で改善した。中性脂肪は糖尿病ラットで低下傾向、総コレステロールは有意な変化なし。組織学的には、STはランゲルハンス島の萎縮を軽減し、SUは萎縮や過形成などの変化を引き起こした。結論として、STは安全で、SUは低濃度またはSTとの併用が推奨される。

この要約は公開抄録のみを根拠にAIが機械的に生成したものです。正確な内容は原文を確認してください。

抄録

Numerous food organizations have identified excessive calorie consumption and accompanying ailments as significant health risks associated with high sugar consumption. Administering stevioside (ST), sucralose (SU), and the two synergically (SU+ST) affected normal rats' weight gain. In the current study, SU showed the highest undesired effect. Indeed, administering the three treatments to diabetic rats (DR) did not improve the rats' weight gain. Although, insulin injection synergically with the treatments improved the weight gain, as recorded after three weeks. The best-improving rate was observed in the ST group. After the administration of ST and ST+SU to the DR, the blood glucose level (GL) was positively affected, with SU having no effects on reducing the GL. A considerable reduction in serum insulin (SIL) was noted in the DR+SU group. On the contrary, ST did not negatively affect the SIL, rather an improvement was recorded. In addition, giving SU did not significantly affect the ALT level in the DR or normal rats (NR). A significant improvement in total bilirubin (TBILI) was observed when insulin was injected with ST or SU in DR groups. Further, triglycerides (TG) after administering ST, SU, or ST+SU to NR had no significant difference compared to the control group (NR). Although, the three treatments markedly but not significantly lowered TG in the DR. For total cholesterol (CHO), both DR and NR had no significant effect after the three treatments. No histopathological alterations were recorded in the NR group. Diffuse and severe atrophy of the islands of Langerhans due to depletion of their cells and mild papillary hyperplasia of the pancreatic ducts were represented by a slightly folded ductal basement membrane and newly formed ductules in STZ-DR. Simultaneous atrophy and absence of the cells of islands of Langerhans besides ductal hyperplasia were evident in DR+SU. Hyperplastic ductal epithelium and atrophic Langerhans cells were seen in DR+SU+In. Degeneration and mild atrophy were observed in the islands of Langerhans structures. There was essentially no noticeable change after utilizing ST. A slight shrinkage of the Langerhans' islets was detected in DR+ST. In DR+ST+In, no histopathological alterations in the islands of Langerhans were recorded. Congestion in the stromal blood vessels associated with degenerative and necrotic changes in the cells of the islands of Langerhans in DR+SU+ST was observed. In NR+SU, congestion of the blood vessels associated with mild atrophy in the islands of Langerhans and dilatation in stromal blood vessels was noticed. In conclusion, ST is safe, and SU should be taken cautiously, such as mixing with ST and/or taken at a very low concentration to avoid its drastic effect on the human body.

MeSH

AnimalsBlood GlucoseDiabetes Mellitus, ExperimentalDiterpenes, KauraneGlucosidesHumansHyperplasiaInsulinInsulin ResistanceIslets of LangerhansRatsSucroseWeight Gain

DOI 10.3390/molecules28030940

PMID 36770608

原文・出典を見る →